Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
5.42
0.00 (0.00%)
Aug 4, 2025, 11:51 AM - Market open
Veren Market Cap
Portage Biotech has a market cap or net worth of $12.35 million as of August 4, 2025. Its market cap has increased by 225.21% in one year.
Market Cap
12.35M
Enterprise Value
10.68M
1-Year Change
225.21%
Ranking
Category
Stock Price
5.42
Market Cap Chart
Since June 5, 2013, Portage Biotech's market cap has decreased from $27.39M to $12.35M, a decrease of -54.91%. That is a compound annual growth rate of -6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 12.35M | 113.08% |
| Dec 31, 2024 | 5.80M | -83.90% |
| Dec 29, 2023 | 36.00M | -60.12% |
| Dec 30, 2022 | 90.26M | -36.96% |
| Dec 31, 2021 | 143.18M | -39.51% |
| Dec 31, 2020 | 236.71M | 131.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |